NCT04610554View on ClinicalTrials.gov

Lung Diffusing Capacity for Nitric Oxide and Carbon Monoxide Early After Mild-to-severe COVID-19

CompletedOBSERVATIONAL
Enrollment

74

Participants

Timeline

Start Date

May 14, 2020

Primary Completion Date

October 12, 2020

Study Completion Date

October 12, 2020

Conditions
COVID-19 Pneumonia
Trial Locations (1)

16132

IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa

All Listed Sponsors
lead

IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy

OTHER

NCT04610554 - Lung Diffusing Capacity for Nitric Oxide and Carbon Monoxide Early After Mild-to-severe COVID-19 | Biotech Hunter | Biotech Hunter